missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies EasySep™ Human CD3 Positive Selection Kit II

Product Code. 16675635
Encompass
Change view
Click to view available options
Quantity:
1 x 109 cells
Unit Size:
Each
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16675635 1 x 109 cells Each
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 16675635 Supplier STEMCELL Technologies Supplier No. 17851

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Immunomagnetic positive selection of human CD3+ cells (e.g. T cells)

  • The EasySep™ Human CD3 Positive Selection Kit II is designed to isolate CD3+ cells from fresh or previously frozen peripheral blood mononuclear cells by positive selection
  • Desired cells are targeted with Tetrameric Antibody Complexes recognizing CD3 and dextran-coated magnetic particles
  • The cocktail also contains an antibody to human Fc receptor to minimize nonspecific binding
  • Labeled cells are separated using an EasySep™ magnet without the use of columns
  • Cells of interest remain in the tube while unwanted cells are poured off
  • The CD3 antigen is expressed on all T cells and CD56+ NKT cells
  • This product replaces the EasySep™ Human CD3 Positive Selection Kit (Catalog #18051) for even faster cell isolations

Specifications

Cell Type T Cells
For Use With (Application) Cell Isolation
Quantity 1 x 109 cells
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.